Nuveen Asset Management’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $14.6M | Buy |
2,633,918
+617,009
| +31% | +$3.42M | ﹤0.01% | 1368 |
|
|
2024
Q3 | $16.8M | Buy |
2,016,909
+1,269,467
| +170% | +$10.6M | ﹤0.01% | 1301 |
|
|
2024
Q2 | $5.09M | Buy |
747,442
+587,870
| +368% | +$4M | ﹤0.01% | 1945 |
|
|
2024
Q1 | $1.05M | Buy |
159,572
+2,940
| +2% | +$19.3K | ﹤0.01% | 2689 |
|
|
2023
Q4 | $1.02M | Buy |
156,632
+37,952
| +32% | +$246K | ﹤0.01% | 2729 |
|
|
2023
Q3 | $597K | Sell |
118,680
-57,458
| -33% | -$289K | ﹤0.01% | 2784 |
|
|
2023
Q2 | $1.54M | Buy |
+176,138
| New | +$1.54M | ﹤0.01% | 2465 |
|
|
2022
Q2 | – | Sell |
-14,237
| Closed | -$43K | – | 3392 |
|
|
2022
Q1 | $43K | Hold |
14,237
| – | – | ﹤0.01% | 3279 |
|
|
2021
Q4 | $83K | Hold |
14,237
| – | – | ﹤0.01% | 3289 |
|
|
2021
Q3 | $150K | Hold |
14,237
| – | – | ﹤0.01% | 3297 |
|
|
2021
Q2 | $175K | Buy |
14,237
+152
| +1% | +$1.87K | ﹤0.01% | 3257 |
|
|
2021
Q1 | $310K | Buy |
+14,085
| New | +$310K | ﹤0.01% | 3166 |
|